Protean Biodiagnostics is Biotechnology in United States that focus on rapid molecular diagnostics business. Founded in 2017. They cover business area such as operator, precision oncology, a focus, community cancer center, community oncologist, digital pathology, AI, ultra-rapid molecular diagnostic, genetic, liquid biopsy, patient, new treatment, access, advanced tissue and blood diagnostic.
2017
( 7 years old in 2024 )
Rapid Molecular Diagnostics
-
6555 Sanger Road
Suite 260
Orlando, FL 32827
United States
Private
operatorprecision oncologya focuscommunity cancer centercommunity oncologistdigital pathologyAIultra-rapid molecular diagnosticgeneticliquid biopsypatientnew treatmentaccessadvanced tissue and blood diagnostic
* We use standard office opening hours in near Protean Biodiagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Protean Biodiagnostics is Biotechnology business from United States that founded in 2017 (7 years old in 2024), Protean Biodiagnostics business is focusing on Rapid Molecular Diagnostics.
Protean Biodiagnostics headquarter office and corporate office address is located in 6555 Sanger Road Suite 260 Orlando, FL 32827 United States.
Protean Biodiagnostics was founded in United States.
In 2024, Protean Biodiagnostics is currently focus on rapid molecular diagnostics sector.
Above is snippet of Google Trends for "rapid molecular diagnostics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Protean Biodiagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.